Log in to save to my catalogue

MyProstateScore in men considering repeat biopsy: validation of a simple testing approach

MyProstateScore in men considering repeat biopsy: validation of a simple testing approach

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10310885

MyProstateScore in men considering repeat biopsy: validation of a simple testing approach

About this item

Full title

MyProstateScore in men considering repeat biopsy: validation of a simple testing approach

Publisher

London: Nature Publishing Group UK

Journal title

Prostate cancer and prostatic diseases, 2023-09, Vol.26 (3), p.563-567

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Background
Men with persistent risk of Grade Group (GG) ≥ 2 cancer after a negative biopsy present a unique clinical challenge. The validated MyProstateScore test is clinically-available for pre-biopsy risk stratification. In biopsy-naïve patients, we recently validated a straightforward testing approach to rule-out GG ≥ 2 cancer with 98% negati...

Alternative Titles

Full title

MyProstateScore in men considering repeat biopsy: validation of a simple testing approach

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10310885

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10310885

Other Identifiers

ISSN

1365-7852

E-ISSN

1476-5608

DOI

10.1038/s41391-022-00633-3

How to access this item